Get started
Author

Miladys Limonta Fernández

Observed names: Limonta Miladys, Limonta-Fernández, Miladys, M. Limonta, M. Limonta Fernández, Miladys Limonta, Miladys Limonta-Fernandez, Miladys Limonta-Fernández, Miladys Limonta‐Fernández
ORCID: 0000-0002-1664-5255
Observed ORCID: 0000-0002-1664-5255
OpenAlex ID: A5045572356
Safety, Tolerability, and Immunogenicity of a SARS-CoV-2 Recombinant Spike RBD Protein Vaccine: A Randomised, Double-Blind, Placebo-Controlled, Phase 1-2 Clinical Trial (ABDALA Study)
2022 · Francisco Hernández-Bernal, Maria C. Ricardo-Cobas, et al. · EClinicalMedicine · 70
PDF
An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen
2022 · Miladys Limonta-Fernández, Glay Chinea-Santiago, et al. · New Biotechnology · 69
Cuban Abdala Vaccine: Effectiveness in Preventing Severe Disease and Death from COVID-19 in Havana, Cuba; a Cohort Study
2022 · Pedro I. Más-Bermejo, Félix O. Dickinson-Meneses, et al. · The Lancet Regional Health - Americas · 52
A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study)
2023 · Francisco Hernández-Bernal, Maria C. Ricardo-Cobas, et al. · The Lancet Regional Health - Americas · 30
Immunization with a DNA vaccine candidate in chronic hepatitis C patients is safe, well tolerated and does not impair immune response induction after anti‐hepatitis B vaccination
2009 · Marlen Castellanos, Zurina Cinza, et al. · The Journal of Gene Medicine · 29
Recombinant Human Epidermal Growth Factor/Quatsome Nanoconjugates: A Robust Topical Delivery System for Complex Wound Healing
2021 · Lidia Ferrer‐Tasies, Hector Santana, et al. · Advanced Therapeutics · 27
PDF
Conformational and Thermal Stability Improvements for the Large-Scale Production of Yeast-Derived Rabbit Hemorrhagic Disease Virus-Like Particles as Multipurpose Vaccine
2013 · Erlinda Fernández, Jorge R. Toledo, et al. · PLoS ONE · 24
PDF
Epidermal Growth Factor Intralesional Delivery in Chronic Wounds: The Pioneer and Standalone Technique for Reversing Wound Chronicity and Promoting Sustainable Healing
2024 · Jorge Berlanga-Acosta, Ariana Garcia-Ojalvo, et al. · International Journal of Molecular Sciences · 21
PDF
In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2 in a single ESI–MS spectrum
2021 · Luis Ariel Espinosa, Yassel Ramos, et al. · Analytical and Bioanalytical Chemistry · 16
PDF
Immunogenicity and Safety Assessment of a SARS-CoV-2 Recombinant Spike RBD Protein Vaccine (Abdala) in Paediatric Ages 3 to 18 Years Old: A Double-Blinded, Multicentre, Randomised, Phase 1/2 Clinical Trial (ISMAELILLO Study)
2022 · Zurina Cinza-Estévez, Sonia Resik-Aguirre, et al. · EClinicalMedicine · 11
PDF
Evaluation of methodologies to determine the effect of specific active immunotherapy on VEGF levels in phase I clinical trial patients with advanced solid tumors
2018 · Javier Sánchez Ramírez, Mónica Bequet-Romero, et al. · Heliyon · 10
PDF
Simulation for the recovery of plasmid for a DNA vaccine
2013 · Miladys Limonta, Nika Lendero Krajnc, et al. · Biochemical Engineering Journal · 10
Effect of the Selection Marker on the Viability and Plasmid Stability of Two Human Proteins with Neurotrophic Action Expressed inEscherichia coli
1999 · Yssel Mendoza Marı́, Angela Estela Sosa Espinosa, et al. · Biochemical and Biophysical Research Communications · 10
Safety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1–2 Clinical Trial
2024 · Gilda Lemos-Pérez, Yinet Barrese-Pérez, et al. · Vaccines · 8
PDF
Cuban Vaccines Abdala and Mambisa Against Covid-19
2023 · G. Guillen, M. Limonta, et al. · International Journal of Infectious Diseases · 6
Impact on antitumor response using a new adjuvant preparation as a component of a human papillomavirus type 16 therapeutic vaccine candidate
2019 · Milaid Granadillo, Aileen Batte, et al. · Vaccine · 6
LALF32-51-E7 therapeutic vaccine induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the lungs
2017 · Milaid Granadillo, Aileen Batte, et al. · Clinical & Experimental Metastasis · 5
The LALF32-51 peptide as component of HPV therapeutic vaccine circumvents the alum-mediated inhibition of IL-12 and promotes a Th1 response
2015 · Milaid Granadillo, Alain B. Alfonso, et al. · Journal of Cellular Immunotherapy · 5
PDF
HEBERSaVax immunotherapy combined with first‐line chemotherapy in advanced ovarian cancer: Phase II CENTAURO ‐4 trial results
2025 · Francisco Hernández‐Bernal, Katty‐Hind Selman‐Housein Bernal, et al. · International Journal of Cancer · 4
PDF
Hepatitis B Surface Antigen Particle Purification by Immunoaffinity Chromatography Based on CDI-CB.Hep-1 mAb Monolithic Supports
2018 · Rodolfo Valdés, Urh Černigoj, et al. · BioProcessing Journal · 4
Uso del interferón leucocitario durante una epidemia de dengue hemorrágico (virus tipo II) en Cuba
1984 · Miladys Limonta-Fernández, Ramírez, et al. · 4
Efficacy and safety of Abdala COVID-19 subunit vaccine in children and adolescents: An open-label, single-arm, phase 2 trial (MEÑIQUE)
2024 · Francisco Hernández-Bernal, Joel Quintana-Guerra, et al. · Vaccine · 3
Correction to “Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study” [The Lancet Regional Health – Americas 2022; 16: 100366] https://doi.org/10.1016/j.lana.2022.100366
2022 · Pedro I. Más-Bermejo, Félix O. Dickinson-Meneses, et al. · The Lancet Regional Health - Americas · 2
PDF
CIGB-552: Anticancer peptide with multimodal mechanisms and clinical promise for colorectal cancer
2025 · J. R. Fernandez Masso, B. Oliva Arguelles, et al. · Research and Practical Medicine Journal · 1
Structural and Functional Glycosylation of the Abdala COVID-19 Vaccine
2025 · Sean A Burnap, Valeria Calvaresi, et al. · Glycobiology · 1
PDF
Works count: 43
Citation count: 430
H-index: 10
I10-index: 13
Year
Topic
Type